Cargando…

Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers

Immunogenic cell death (ICD) is a regulated form of cell death that induces the activation of both innate and adaptive immune responses through the release of damage-associated molecular patterns (DAMPs) and their subsequent recognition by pattern-recognition receptors (PRRs), generating specific CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiaravalli, Marta, Spring, Alexia, Agostini, Antonio, Piro, Geny, Carbone, Carmine, Tortora, Giampaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563749/ https://www.ncbi.nlm.nih.gov/pubmed/36230995 http://dx.doi.org/10.3390/cells11193033

Ejemplares similares

Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification
por: Nasca, Vincenzo, et al.
Publicado: (2020)

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
por: Tamburrino, Anna, et al.
Publicado: (2013)

Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches
por: Cencioni, Chiara, et al.
Publicado: (2022)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response
por: Piro, Geny, et al.
Publicado: (2021)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
por: Cascetta, Priscilla, et al.
Publicado: (2018)

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
por: Carbone, Carmine, et al.
Publicado: (2018)

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
por: Piro, Geny, et al.
Publicado: (2019)

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
por: Carbone, Carmine, et al.
Publicado: (2021)

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
por: Carbone, Carmine, et al.
Publicado: (2019)

The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
por: Ferrara, Miriam Grazia, et al.
Publicado: (2021)

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around
por: Gkountakos, Anastasios, et al.
Publicado: (2019)

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis
por: Carbone, Carmine, et al.
Publicado: (2014)

Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis
por: Tiberti, Natalia, et al.
Publicado: (2020)

The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review)
por: Songjang, Worawat, et al.
Publicado: (2021)

Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
por: Stefani, Alessio, et al.
Publicado: (2022)

Targeting immunogenic cell death in cancer
por: Ahmed, Asma, et al.
Publicado: (2020)

A circulating T(H)2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
por: Piro, Geny, et al.
Publicado: (2017)

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
por: Di Grazia, Antonio, et al.
Publicado: (2020)

Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
por: Agostini, Antonio, et al.
Publicado: (2023)

Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021)

Molecular alterations in basal cell carcinoma subtypes
por: Di Nardo, Lucia, et al.
Publicado: (2021)

Immunogenic cell death in cancer therapy: Present and emerging inducers
por: Zhou, Jingyi, et al.
Publicado: (2019)

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
por: Filippini, Dea, et al.
Publicado: (2019)

Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo
por: Lupo, Francesca, et al.
Publicado: (2020)

Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)
por: Vita, Emanuele, et al.
Publicado: (2023)

Immunogenic Cell Death in Cancer Therapy
por: Troitskaya, O. S., et al.
Publicado: (2022)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody
por: Nadal, Lisa, et al.
Publicado: (2022)

Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
por: Alzeibak, Razan, et al.
Publicado: (2021)

Engineering Calreticulin-Targeting Monobodies to Detect Immunogenic Cell Death in Cancer Chemotherapy
por: Zhang, Ying, et al.
Publicado: (2021)

Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
por: Bao, Xuhui, et al.
Publicado: (2022)

Immunogenic Cell Death-Based Cancer Vaccines
por: Jin, Ming-Zhu, et al.
Publicado: (2021)

Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy
por: Jafari, Sevda, et al.
Publicado: (2023)

Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
por: Li, Wei, et al.
Publicado: (2019)

Correction: Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Publicado: (2021)

The Achilles’ heel of cancer: targeting tumors via lysosome-induced immunogenic cell death
por: Iulianna, Taritsa, et al.
Publicado: (2022)

From targeted therapy to a novel way: Immunogenic cell death in lung cancer
por: Xu, Jiawei, et al.
Publicado: (2022)

Afzelin induces immunogenic cell death against lung cancer by targeting NQO2
por: Xia, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u44j2ohd9coes9315iagejn70s